Lownie Stephen P, Pelz David M, Lee Donald H, Men Suleyman, Gulka Irene, Kalapos Paul
Department of Diagnostic Radiology, Division of Neurosurgery, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.
AJNR Am J Neuroradiol. 2005 May;26(5):1241-8.
One of the limitations of carotid artery angioplasty is the potential for embolic stroke. Our purpose was to assess whether the force of a self-expanding stent alone is usually sufficient to dilate severely stenotic atherosclerotic plaques without the deliberate use of an angioplasty balloon. If so, the procedural stroke risk might be reduced.
Over a 30-month period, 21 consecutive patients were prospectively identified with severe symptomatic carotid artery stenosis (>70% NASCET [North American Symptomatic Carotid Endarterectomy Trial]) and relative indications for endovascular treatment. All underwent treatment with the aim of deploying a self-expanding stent across the stenosis without the use of angioplasty balloons or distal protection devices.
Stent deployment was successful in 20/21 patients. In one patient, the stent could not be deployed without balloon predilatation and a stroke occurred. In the other 20 patients, angiography before and immediately after stent deployment showed a reduction in the mean stenosis from 83% to 49%. A second periprocedural stroke occurred as a result of early stent thrombosis at 4 days in a patient who stopped Acetylsalicylic acid while undergoing bowel preparation for colon surgery. He made a good recovery. Average duration of follow-up imaging was 19 months (range, 1-44 months). During the follow-up period there were four deaths, all unrelated to the carotid disease, and no major strokes. At 5-11 months, the average residual stenosis was 21%, which remained stable in 16 of the 18 patients studied between 12 and 44 months (average, 24 months). At last follow-up, in these 16 the mean peak systolic velocity was 123 cm/s (range, 60-238 cm/s) and the mean internal-to-common carotid ratio was 1.8. The other two patients were long-term failures of the "stent-only" approach. In one patient, a heavily calcified plaque prevented stent expansion and the artery occluded at 18 months with a minor stroke. In the second patient, a recurrent stenosis developed at 16 months with one episode of transient ischemic attack.
Deployment of a self-expanding stent alone resulted in a favorable and more gradual reduction of severe symptomatic carotid stenosis. Improvements in stent profile and chronic outward force may widen the indications for simple stent placement without the use of balloons or adjunctive protection devices.
颈动脉血管成形术的局限性之一是存在发生栓塞性中风的可能性。我们的目的是评估仅使用自膨式支架的力量是否通常足以扩张严重狭窄的动脉粥样硬化斑块,而无需刻意使用血管成形术球囊。如果是这样,手术中风风险可能会降低。
在30个月的时间里,前瞻性地确定了21例连续性患者,这些患者患有严重的有症状颈动脉狭窄(北美症状性颈动脉内膜切除术试验中狭窄程度>70%)且有血管内治疗的相对指征。所有患者均接受治疗,目的是在不使用血管成形术球囊或远端保护装置的情况下,将自膨式支架跨过狭窄部位进行置入。
21例患者中有20例成功置入支架。1例患者在未进行球囊预扩张的情况下无法置入支架,发生了中风。在其他20例患者中,支架置入前后的血管造影显示平均狭窄率从83%降至49%。1例患者在接受结肠手术肠道准备期间停用阿司匹林,术后4天因早期支架血栓形成发生了第二次围手术期中风。该患者恢复良好。平均随访成像时间为19个月(范围1 - 44个月)。随访期间有4例死亡,均与颈动脉疾病无关,且无重大中风发生。在5 - 11个月时,平均残余狭窄率为21%,在18例研究患者中有16例在12至44个月(平均24个月)期间保持稳定。在最后一次随访时,这16例患者的平均收缩期峰值流速为123 cm/s(范围60 - 238 cm/s),平均颈内动脉与颈总动脉比值为1.8。另外2例患者是“仅使用支架”方法的长期失败者。1例患者因严重钙化斑块阻碍支架扩张,18个月时动脉闭塞并发生轻微中风。另1例患者在16个月时出现再发狭窄,并发生了1次短暂性脑缺血发作。
仅置入自膨式支架可使严重有症状颈动脉狭窄得到良好且更渐进的改善。支架外形和慢性向外作用力的改进可能会扩大单纯支架置入的适应证,而无需使用球囊或辅助保护装置。